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Abstract: In the setting of chronic hepatitis C virus (HCV) infection,
changes in natural killer (NK) cells have been shown to reflect activation
in response to virus stimulation. The contribution of individual natural
cytotoxicity receptors to HCV infection remains to be clarified. NKp44
is the sole specific natural cytotoxicity receptor expressed only on
activated NK cells.
In this study, peripheral blood and liver NK-cell subsets were
purified from 31 patients with chronic C hepatitis or nonalcoholic
steatohepatitis, and then characterized by flow cytometry. Their poly-
functional activity was determined by expression of the CD107a
degranulation marker, together with intracellular cytokine production.
Unlike the patients with nonalcoholic steatohepatitis, patients with
chronic HCV infection had a higher frequency of NKp44þ NK cells in
the liver than in their peripheral blood (P< 0.0001). Intrahepatic
NKp44þ NK cells from HCVþ individuals produced higher levels of
tumor necrosis factor-a than did NKp44 NK cells (P¼ 0.0011).
Importantly, the frequency of intrahepatic NKp44þ NK cells was
correlated with both HCV-RNA levels (P¼ 0.0234) and stage of fibrosis
(P¼ 0.0003).
Our findings suggest that the accumulation of intrahepatic tumor
necrosis factor-a-producing NKp44þ resident NK cells play a role in the
liver damage associated with chronic HCV infection.
(Medicine 95(19):e3678)
Abbreviations: HCV = hepatitis C virus, IFN-g = interferon-Patrice Debre´, M Asselah, MD,
, and Vincent Vieillard, PhDINTRODUCTION
A pproximately 170 million people worldwide are infectedwith hepatitis C virus (HCV), many of them diagnosed only
after decades of chronic infection. Only a minority of patients
can clear the virus spontaneously during acute infection. HCV
remains a leading cause of liver cirrhosis and hepatocellular
carcinoma, despite great progress in the development of direct-
acting antivirals (DAAs) able to cure more than 90% of HCV
genotype 1-infected patients after 12 weeks of treatment.1 The
mechanisms associated with both the failure of viral clearance
and the development of chronic infection are not yet well
understood. It has, however, been observed that most patients
are unable to clear the virus and thus develop viral persistence.1
Natural killer (NK) cells are involved in every stage of HCV
infection. As a major component of the intrahepatic lymphocyte
pool, they are likely to be important sentinels that survey the
liver for signs of damage or cellular stress. Accordingly, HCV
must subvert NK cell-mediated responses to establish persistent
infection.2–6 NK cells participate in viral clearance by killing
infected cells directly, through the release of cytotoxic mol-
ecules, such as perforin and granzymes, and by producing
cytokines such as interferon (IFN)-g and tumor necrosis factor
(TNF)-a. Under normal immune surveillance, NK cells express
inhibitory receptors, including killer Ig-like receptors (KIR), Ig-
like transcript 2, and the CD94:NKG2A heterodimer, which
recognize Major histocompatibility complex class I molecules
as their cognate ligands. Cytotoxicity, however, occurs when
stimulatory signals outweigh HLA-I inhibition. Several of these
activating receptors have been characterized, including
NKG2C, NKG2D, and the natural cytotoxicity receptors
(NCRs): NKp30, NKp44, and NKp46.7–9 Compared with the
constitutively expressed NKp30 and NKp46 receptors, NKp44
is especially interesting because it is induced only after cell
activation.10 NKp44 triggers NK-cell cytotoxicity upon recog-
nition of a new mixed lineage leukemia 5 (MLL5) isoform,
expressed only on stressed cells.11,12 Several ‘‘pathogenic’’
ligands for NKp44 that stimulate NK-cell response have been
described, including influenza virus hemagglutinin and viral
Hemagglutinin-neuraminidase.9 NKp44 also interacts with the
E glycoprotein of the dengue and West Nile viruses.13
Several lines of evidence indicate that NK cells play a role
in acute HCV infection. Khakoo et al14 reported that individuals
homozygous for the genes encoding KIR2DL3, an inhibitory
NK cell receptor, and its ligand are more likely than others to
resolve infection by HCV, consistent with a subsequent finding
that KIR2DL3þNKG2A NK cells seem to mediate early
control of HCV infection, before seroconversion.15 Further-ver the past decade have reported that
n is characterized by functionally and
d NK-cell responses that may contribute
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to the progression of liver disease1,3,5,16,17 and are partially
restored during antiviral therapy.18 The scarcity of data about
intrahepatic NK cells and their discrepancy concerning NKp44
in patients with chronic HCV infection19,20 prompted us to
compare peripheral blood and liver NK cells from these patients
to evaluate the role of intrahepatic NKp44þ NK cells in the
immunopathogenesis of this disease.
METHODS
Patient Populations
This study included 31 patients scheduled for liver biopsy
at Beaujon Hospital (Clichy, France) from December 2009
through February 2014: 21 with chronic HCV infection and 10
with nonalcoholic steatohepatitis (NASH) (Table 1). The
study protocol conformed to the ethical guidelines of the
1975 Declaration of Helsinki and was approved by the Comite´
de Protection des Personnes (CCP), Ile de France IV (# 2009/
19NI). All patients provided written informed consent.
Infected patients were included if they had chronic HCV
infection, defined by seropositivity for HCV-RNA, respect-
ively, for at least 12 months. Coinfected patients, patients on
antiviral treatment, and patients with liver transplants were
excluded. Staging and grading of pathology were determined
as part of the hospital’s routine diagnostic work-up. An
experienced pathologist, blinded to the clinical and laboratory
data, analyzed the liver biopsy specimens according to the
Metavir scoring system: necroinflammatory activity (A) was
graded as A0 (absent), A1 (mild), A2 (moderate), or A3
Nel et al(severe). Fibrosis stage (F) was scored as F0 (absent), F1
(portal fibrosis), F2 (portal fibrosis with >1 septum), F3
(septal fibrosis), or F4 (cirrhosis).21
TABLE 1. Characteristics of Subjects Enrolled in This Study
Characteristics HCV-NASH
Number 21 10
Mean age in yrs (range) 54 (41–70) 49 (26–67)
Male:female (n) 14:7 6:4
Median viral load (range) 1.1 106 (3.6 104–7.1 106)
Necroinflammation
activity (n, %)
A0 to A1 16 (76.2) 7 (70.0)
A2 to A3 5 (23.8) 3 (30.0)
Fibrosis stage (n, %)
F0 to F2 12 (57.1) 8 (80.0)
F3 to F4 9 (42.9) 2 (20.0)






Median ALT (range), IU/L 93 (24–332) 80 (17–286)
Median AST (range), IU/L 60 (32–239) 65 (20–305)
Median gGT (range), IU/L 78 (16–549) 223 (55–810)
gGT¼ gamma glutamyl-transferase, ALT¼ alanine aminotransfer-
ase, AST¼ aspartate aminotransferase, HCV¼ hepatitis C virus,
IU¼ International unit, n¼ number, NASH¼ nonalcoholic steatohepa-
titis.
2 | www.md-journal.comSample Preparation
Peripheral blood samples were collected in heparin tubes
the same day as the biopsy. Liver biopsies were prepared as
previously described.11,22 Briefly, they were mechanically
dissociated through a 70-mm cell strainer (BD Pharmingen),
before incubation with 10 mg/mL collagenase II-S (Sigma-
Aldrich) in medium containing trypsin inhibitor (Sigma-
Aldich) and DNase I (Roche Life Science) for 1.5 hours at
378C on a rotary shaker. After additional washes, the suspen-
sion was filtered through a 40-mm cell strainer, centrifuged,
and used directly for phenotypic and/or functional assays
analyzed by flow cytometry.
Flow Cytometric Analysis
Natural killer cells were analyzed after staining with an
appropriate monoclonal antibody (mAb) cocktail, as previously
described22,23: anti-CD45 (#J33), anti-CD3 (#UCHT1), anti-
CD56 (#N901), anti-CD16 (#3G8), anti-CD159a/NKG2A
(#Z199), CD335/NKp46 (#BAB281), anti-CD336/NKp44
(#Z231), anti-CD69 (#FN50), anti-Cx3CR1 (#2A9–1), and
anti-CD127 (#R34.34) mAbs from Coulter; anti-CD62L
(#DREG-56; BD Pharmingen), anti-CD337/NKp30 (#AF29–
4D12), and anti-NKG2C (#134591) mAbs from R&D systems,
and also a cocktail of anti-panKIR-L including anti-KIR2DL1
(#143211) and anti-KIR3DL1 (#177407); and anti-KIR2DL2/
KIR2DL3 (#DX27; Miltenyi Biotech) mAbs. Populations of
interest within the CD45þ lymphocytic population were gated
on CD3CD56þ NK cells. At least 20,000 CD45þ cells or 1000
CD3-CD56þ NK cells were acquired on a Gallios flow cyt-
ometer (Beckman Coulter) and then analyzed with Flow
Jo version 9 (TreeStar) (Supplementary Figure 1, http://
links.lww.com/MD/A971 ), as described.22
Intracellular Cytokine Production and
Polyfunctionality Assay
Functional capacity of NKp44þ NK cells compartment
has been tested in 10 samples from peripheral blood and liver
biopsies. Cells were incubated overnight with 10 ng/mL inter-
leukin (IL)-12 and 100 ng/mL IL-18 at 378C and 5% CO2.
They were thereafter incubated for 5 hours in the presence of
Golgi Stop and Golgi Plug solutions (BD Biosciences), and
then stained with cell surface markers (anti-CD3, anti-CD56,
and anti-NKp44 mAbs). Next they were fixed, permeabilized
with a cytofix/cytoperm kit (Becton Dickinson), and then
stained intracellularly with anti-IFN-g (#B27; Becton Dick-
inson) and anti-TNF-a (#Mab11; eBiosciences) mAbs, as
described.23
For the polyfunctionality assays, nonstimulated NK cells
were incubated in the presence of the standard K562 target
cells (ATCC CCL243) and hepatocellular carcinoma Hep G2
cells, kindly provided by Professor D. Mazier (CIMI-Paris,
Paris, France), at an effector:target (E:T) cell ratio of 1:1 in the
presence of an anti-CD107a mAb (#H4A3; Becton Dickin-
son), used as a degranulation cell-surface marker, as
described.22,23 Data were analyzed with Flow Jo version 9
(TreeStar), and the rates of NK cells positive for 0, 1, 2, or 3
functions were defined with this software’s ‘‘Boolean gate’’
algorithm. Pie charts, generated with Spice software (NIAI
freeware),24 present the frequency of NK cells positive for 0,
Medicine  Volume 95, Number 19, May 20161, 2, or 3 responses (to CD107a, IFN-g, and/or TNF-a). Arcs
depict the frequency of cells positive for each of CD107a,
IFN-g, and TNF-a.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
FIGURE 1. Accumulation of intrahepatic NKp44þ NK cells in chronically HCV-infected patients. Flow cytometry analysis of NK cells from
patients with HCV (n¼21) or NASH (n¼10) (Table 1). A, Frequency of peripheral blood (PB) and intrahepatic (liver) CD3CD56þ NK
cells. B, Expression of NKp44 gated on CD3CD56þ cells in peripheral blood mononuclear cells (PBMC) and liver biopsies. Statistical
analysis used the Wilcoxon rank test to compare paired blood and intrahepatic samples. () P<0.01; () P<0.001. C,
Representative phenotypic characterization of intrahepatic NKp44þ NK cells (bold black line), compared with NKp44 cells (light black
line) and isotype controls (gray panel). D, Frequency of CD69þ (left panel) and NKp30þ (right panel) within intrahepatic NKp44 and
NKp44þ NK-cell subsets from the 21 HCV-infected patients. HCV¼hepatitis C virus, NASH¼nonalcoholic steatohepatitis, NK¼natural
killer, ns¼nonsignificant.
Medicine  Volume 95, Number 19, May 2016 Intrahepatic NKp44þ NK Cells in Chronic HCV
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved. www.md-journal.com | 3
FIGURE 2. Correlation between intrahepatic NKp44þ NK cells,
virological and clinical parameters in chronically HCV-infected
patients (n¼21). Linear regression between the frequency of
intrahepatic NKp44þ NK cells and the fibrosis stage (F1–F4) (A)
Medicine  Volume 95, Number 19, May 2016Quantification of Cytokines
Cytokine analysis was performed in the plasma of the 21
HCVþ patients, with Quantikine IFN-g and TNF-a immunoas-
says (R&D Systems), according to the manufacturer’s proto-
cols. Frozen plasma samples (preserved at 80 8C) were used
for testing after clarification by centrifugation (30 min at 1000g)
at 48C. Experiments were performed in duplicates. The sensi-
tivity was 8.0 pg/mL for IFN-g and 1.6 pg/mL for TNF-a.
Statistical Analysis
Statistical analyses were performed with Prism-5 software
(GraphPad Software). The nonparametric ‘‘Wilcoxon rank test’’
was used to compare 2 related samples. Statistical significance
was defined by a P value less than 0.05 with a 2-tailed test.
Nonparametric correlations were assessed by determining
Spearman rank correlation coefficient.
RESULTS
Accumulation of Intrahepatic NKp44R NK Cells
in Chronic HCV-infected Patients
Previous reports published on the properties of intrahepatic
NK cells in chronic HCV-infected patients are conflicting,
likely related to limited cell numbers from biopsies or different
gating strategies by flow cytometry.3,16–18,25,26 In this study, we
observed that the overall frequency of NK cells was signifi-
cantly higher in the liver than in the peripheral blood in both
HCV-infected patients and patients with NASH (Figure 1A).
However, in contrast to the patients with NASH, HCVþ patients
showed a significant accumulation of NKp44þ CD3CD56þ
cells in the liver, compared with their blood samples
(P< 0.0001, median 13.5%; Figure 1B).
This observation prompted us to characterize the intrahe-
patic NKp44þ cells from HCVþ patients in more detail. They
did not express either CD127 (IL7Ra) or CD49a, which
indicates that they are distinct from both the NKp44þ invariant
lymphocyte cells (ILC1) in tonsils27 and the liver-resident
CD49aþ NK-cell subset (Figure 1C), consistent with the find-
ings of Marquardt et al.28 Furthermore, compared with periph-
eral NK cells, they did not express high frequencies of CD16,
panKIR-L, CD62L, or Cx3CR1, which is associated with the
migration of circulating CD56dim NK cells to sites of inflam-
mation (Figure 1C and Supplementary Figure 2 , http://
links.lww.com/MD/A971). Although a high frequency of
NKp44þ cells expressed NKG2A, its mean fluorescence inten-
sity (MFI) was slightly lower than in the NKp44 cells
(Figure 1C and Supplementary Figure 2, http://links.lww.-
com/MD/A971). NKp44þ NK cells had a significantly higher
frequency of activation receptor CD69 than did the NKp44-
cells (P< 0.0001; Figure 1D), and a lower frequency of NKp30
(P¼ 0.0003; Figure 1D). Instead, the intrahepatic NKp44þ cells
displayed the profile of activated CD3CD56brightCD16NK-
NKp30low NK cells.
Intrahepatic NKp44R NK Cells are Correlated
With HCV Viral Load and Fibrosis Activity
Next, we attempted to identify any statistical correlations
between the accumulation of intrahepatic NKp44þ cells and
biochemical (serum alanine aminotransferase, aspartate amino-
Nel et altransferase, and gamma glutamyl-transferase), virologic (HCV
genotype, HCV-RNA), and/or clinical (necroinflammatory
activity and fibrosis stage) parameters. No association was
4 | www.md-journal.comfound with HCV genotype, hepatic enzyme levels, or necroin-
flammatory activity (data not shown). However, the frequency
of intrahepatic NKp44þ cells was significantly correlated with
the liver fibrosis stage (P< 0.0001, r¼ 0.89; Figure 2A) and, to
a lesser extent, with viral load (P¼ 0.042, r¼ 0.60; Figure 2B).
Intrahepatic NKp44R NK cells Produce High
Levels of TNF-a in Association With HCV Viral
Load and Fibrosis Activity
We next assessed the overall functional ability of NKp44þ
NK cells within the intrahepatic compartment in 10 of the 13
liver biopsies, with an NKp44 frequency greater than the
median (13.5%) (13.6%–62.2%) (Figure 1B); the 3 last biopsies
were too small size to undergo functional analyses. One of the
main functions of NK cells is the production and release of IFN-
g and TNF-a. After treatment with IL-12 and IL-18, the
frequency of NK cells able to produce IFN-g was lower in
the intrahepatic NKp44þ cells than in the other subsets in the 10
or with viral load (B). The Spearman test showed significant
statistical correlations. HCV¼hepatitis C virus, NK¼natural killer.tested liver biopsies (Figure 3A and B). Consistently with a
previous study,29 the plasma level of IFN-g, in the plasma of the
21 HCVþ patients, was inversely correlated with the stage of
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
FIGURE 3. Lower level of IFN-g in intrahepatic NKp44þ NK cells from HCV-infected patients than in its NKp44 counterparts or in
peripheral blood cells. A, Intracellular production of IFN-g in peripheral blood (PB) and intrahepatic (liver) NKp44 or NKp44þ
CD3CD56þ NK cells before (none) or after overnight stimulation with IL-12 plus IL-18. Samples from 10 of the 13 patients with a
frequency of NKp44þ cells superior to themedian (>13.5%) were tested. Statistical correlation used 1-way analysis of variance with Tukey
multiple comparison tests. B, Representative HCVþ sample for intracellular production of IFN-g in regard of NKp44 expression, gated on
CD3CD56þNK cells fromperipheral blood (PB) and liver biopsy (liver), after overnight stimulationwith IL-12 plus IL-18. C, Correlation of
the plasma level of IFN-g with the frequency of intrahepatic NKp44þ NK cells and the fibrosis stage in the 21 HCV-infected patients. The
es
Medicine  Volume 95, Number 19, May 2016 Intrahepatic NKp44þ NK Cells in Chronic HCVfibrosis (P¼ 0.0325, r¼0.47), and also with the frequency of
intrahepatic NKp44þ NK cells (P¼ 0.0225, r¼0.50;
Figure 3C). Neither intracytoplasmic nor plasma levels of
IFN-g were correlated with viral load (data not shown).
In contrast to IFN-g, the intracellular level of TNF-a was
significantly higher in intrahepatic NKp44þ NK cells than in
either their NKp44 counterparts or the peripheral blood NK
cells, both before and after treatment with IL-12 plus IL-18, in
the 10 tested liver biopsies (Figure 4A and B). The frequency
of NK cells producing TNF-a correlated with the frequency of
Spearman test showed significant statistical correlations. Dotted lin
IFN-g¼ interferon-gamma, NK¼natural killer.intrahepatic NKp44þ NK cells (P¼ 0.0011, r¼ 0.89;
Figure 4C). More importantly, NKp44þ NK cells producing
TNF-a were significantly associated with the stage of fibrosis
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.(P¼ 0.0003, r¼ 0.92; Figure 4C) and viral load (P¼ 0.0234,
r¼ 0.72; Figure 4D). These data are consistent with the
correlation of the TNF-a plasma level with the frequency
of intrahepatic NK cells, in the plasma of the 21 HCVþ
patients (P¼ 0.0388, r¼ 0.46; Supplementary Figure 3,
http://links.lww.com/MD/A971) and still more specifically
with the NKp44þ cell subset (P< 0.0001, r¼ 0.85;
Figure 4E). The TNF-a plasma level was also correlated
with fibrosis stage (P< 0.0001, r¼ 0.71; Figure 4E) and
viral load (P¼ 0.0105, r¼ 0.55; Figure 4D). Of note,
indicate the sensitivity of IFN-g detection. HCV¼hepatitis C virus,the plasma levels of TNF-a and IFN-g were not correlated
with any other laboratory or clinical parameters (data not
shown).
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FIGURE 4. Overproduction of TNF-a by intrahepatic NKp44þ NK cells in chronically HCV-infected patients. A, Intracellular production of
TNF-a in peripheral blood (PB) and intrahepatic (liver)NKp44orNKp44þCD3CD56þNKcells before (none) or after overnight stimulation
with IL-12 plus IL-18. Samples from 10 of the 13 patients with a frequency of NKp44þ cells superior to the median (>13.5%) were tested.
Statistical correlation used the 1-way analysis of variance with Tukey multiple comparison tests. B, Representative HCVþ sample for
intracellular production of TNF-a in regard of NKp44 expression, gated onCD3CD56þNK cells fromperipheral blood (PB) and liver biopsy
(liver), after overnight stimulationwith IL-12 plus IL-18. C, Correlation between the intracellular production of TNF-a in intrahepatic NK cells
and the frequency of intrahepatic NKp44þ NK cells or fibrosis stages. Samples from 10 of the 13 patients with a frequency of NKp44þ cells
superior to the median (>13.5%) were tested. The Spearman test showed significant statistical correlations. D, Correlation between the
intracellular production (n¼10; left panel) or plasma level (n¼21; right panel) of TNF-a and viral load in 10 patients with a frequency of
NKp44þ cells superior to the median (>13.5%). Significant statistical correlations were obtained using the Spearman test. E, Correlation
between the plasma level of TNF-a, the frequency of intrahepatic NKp44þ NK cells, and fibrosis stage in the 21 HCV-infected patients. The
Spearman test showed significant statistical correlations. Dotted lines indicate the sensitivity of TNF-a detection. HCV¼hepatitis C virus,
IL¼ interleukin, NASH¼nonalcoholic steatohepatitis, NK¼natural killer, TNF-a¼ tumor necrosis factor-alpha.
Nel et al Medicine  Volume 95, Number 19, May 2016
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FIGURE 5. Polyfunctional activity of intrahepatic NKp44þ NK cells in chronically HCV-infected patients. Assays were performed with
peripheral blood CD3CD56þNK cells (PB) and NK cells from liver biopsy samples (NKp44 and NKp44þNK-cell subsets) from the same
HCV-infected patients. Pie chart representation of the polyfunctional activity representing the cell-surface expression of CD107a, and
intracellular expression of IFN-g and TNF-a assessed in the absence (none) or presence of K562, Hep G2. Data are the means of the 10
available sampleswith a frequency of NKp44þ cells superior to themedian (>13.5%). HepG2were treatedwith 10mg/mL of anti-NKp44L
(aNKp44L) (right panel) or with IgM isotype control (not shown), as described.11 The Boolean gate function of FlowJo software was used
to determine whether cells expressed 0 (gray), 1 (orange), 2 (purple), or 3 (yellow) functions simultaneously (pie charts). Colored
(blu
phe
Medicine  Volume 95, Number 19, May 2016 Intrahepatic NKp44þ NK Cells in Chronic HCVWe next attempted to determine the capacity of intrahepatic
NKp44þ NK cells to simultaneously degranulate and produce
cytokines (IFN-g and/or TNF-a). This polyfunctional assay was
performed against standard K562 target cells and Hep G2 hepa-
tocellular cells—2 cell lines expressingNKp44L (Supplementary
Figure 3, http://links.lww.com/MD/A971), the cellular ligand of
arcs represent the frequency of NK cells expressing CD107a
NASH¼nonalcoholic steatohepatitis, NK¼natural killer, PB¼periNKp44. Stimulation with both targets produced similar func-
tional profiles in peripheral blood and intrahepatic NKp44 NK-
cell subsets, although the level of polyfunctionality was slightly
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.lower with Hep G2 (Figure 5). Intrahepatic NKp44þ NK cells
were more polyfunctional, than liver and peripheral NKp44
cells, with a strong capacity to simultaneously degranulate and
produce TNF-a (Figure 5); this capacity was lower in the
presence of Hep G2 than K562 target cells, in accordance with
their respective cell surface expression of NKp44L (Supple-
e), IFN-g (red), and TNF-a (green). HCV¼hepatitis C virus,
ral blood, TNF-a¼ tumor necrosis factor-alpha.mentary Figure 4, http://links.lww.com/MD/A971).
Further proof that NKp44 is involved in the NK cytotox-
icity mediated by the intrahepatic NK cells came from the
www.md-journal.com | 7
pretreatment of Hep G2 cells by anti-NKp44L mAb. The
presence of anti-NKp44L mAb strongly inhibited the polyfunc-
tional activity of intrahepatic NKp44þ NK cells (by up to 55%
for their capacity to perform at least 1 function), whereas the
polyfunctionality of their NKp44- counterparts remained
similar to that observed in untreated Hep G2 cells (Figure 5,
right panel). These data suggest that NKp44 expressed by
intrahepatic NK cells could be involved in the destruction of
NKp44L-expressing hepatocytes.
We then considered whether intrahepatic NKp44þ NK
cells were able to interfere with hepatic stellate cells (HSCs),
which are considered the main contributors to liver fibrosis.30
NKp44L expression was tested on the LX-2 human HSC cell
line, which retains key features of primary HSCs.2,31 The failure
of the LX-2 cells, unlike the Hep G2 hepatocellular cells, to
Nel et alapproach targeting NKp44 could present an attractive thera-express NKp44L (Supplementary Figure 4, http://links.lww.-
com/MD/A971), suggests that NKp44þ NK cells do not
target HSCs.
DISCUSSION
This study provides insights into the role of intrahepatic
NK cells in chronic HCV infection. While it has consistently
been reported that peripheral blood NK cells are altered in
chronically HCV-infected patients, compared with healthy
controls,1,3–5 peripheral blood and intrahepatic NK cells behave
differently. One of the most intriguing finding of this study is
the specific and significant accumulation of intrahepatic
NKp44þ NK cells, which is correlated with both viral load
and liver fibrosis in HCV-infected patients. This accumulation
of NKp44þ NK cells has not been observed in vivo in either
chronic HBVþ or NASH patients; it has been described, rarely,
in certain situations, including in a subsets of RORgtþ innate
lymphoid cells (ILCs)24,32,33 and NK cells in the decidua,34 and
in peripheral blood NK cells after infection by the chikungunya
virus35 and by HIV-1.36 The data we present here are consistent
with the hypothesis that NKp44þ NK cells might have deleter-
ious effects in tissue of patients with chronic HCV infection, as
they have previously been suggested to do in the intestinal
mucosa of patients with Crohn disease.37 This contrasts with the
protective roles played by the other NCRs in HCV, such as the
inverse correlation between NKp46bright NK cells and the
severity of liver inflammation,36,38 and the protection against
HCV infection mediated by NKp30.39 The antagonistic roles of
NCRs might be explained by the constitutive expression of
NKp30 and NKp46 on NK cells, compared with the strict
association of the cell-surface induction of NKp44 with cell
activation.9,10 This point also highlights the key role of cell
activation in the development of the liver fibrosis, as described.40
Our in-depth functional analysis of intrahepatic NK cells
from HCV-infected patients revealed that expression of IFN-g
was inversely associated with the frequency of NKp44þ NK
cells, whereas NKp46high NK cells secrete larger amounts of
IFN-g than NKp46dim NK cells.37 These data are consistent
with the antifibrotic function of IFN-g-producing NK cells
mediated by the inhibition of HSCs in a TNF-related apoptosis-
inducing ligand and NKG2D-dependent manner.41 We demon-
strated, however, that TNF-a production was mainly confined to
the intrahepatic NKp44þ NK cells, as previously reported for
RORgtþ ILC, which use the selective expression of TNF-a by
NKp44 to sense the environment.26 It has also been shown that
hepatic dendritic cells acquire the marked ability to stimulate NK
cells TNF-a-dependently in liver fibrosis.42 In view of these
results, it was striking that the serum level of TNF-a correlated
8 | www.md-journal.comsignificantly with the fibrosis stage, as seen in previous studies of
chronicHCV.29,43AsTNF-a is amajor proinflammatory cytokine
involved in several chronic diseases, the in vivo role of NKp44þ
NK-derived TNF-a certainly requires further investigation in
other associated pathologies.
We can thus hypothesize that high expression of TNF-a by
intrahepatic NKp44þ NK cells might result from direct contact
with HCV-infected hepatocytes, as previously shown in vitro.44
Nonetheless, the expression of NKp44 ligands on hepatocytes
must be explored to illuminate more clearly the physiological
relevance of NKp44 engagement in the intrahepatic NK cells of
HCV-infected patients. It is important to note that NKp44L is
expressed onHepG2 hepatocyte cells, but not on LX2HSCs.We
propose that recognition of NKp44 by its ligand on intrahepatic
NK cells from HCV patients might play a role in the TNF-a-
dependent destruction of hepatocytes, while protecting HSCs.
This TNF-a-dependent mechanism could lead to faster pro-
gression of liver fibrosis and cirrhosis, which are the main causes
of morbidity and mortality in patients with HCV infection.45
Together with the previously described specific localiz-
ation of NK cells to necrotic areas in liver biopsy specimens of
HCV-infected patients,25 our data suggest that intrahepatic
TNF-a-producing NKp44þ NK cells play a deleterious role
in immune-mediated liver injury during chronic infection.
Hence, these data deepen our understanding of liver immu-
nology in fibro-inflammatory disease and suggest that an
Medicine  Volume 95, Number 19, May 2016peutic strategy in HCV infection and potentially in other
chronic inflammatory diseases.
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